Bacterial ATP synthase inhibitors as novel antibiotics for Gram positive and Gram negative bacterial infections.

The goal of this research project is to exploit a recent discovery made at Université de Sherbrooke and develop novel antibacterial agents for difficult to treat bacterial infections. The project will target both Gram positive and Gram negative bacteria, using a combination of structural biology, molecular modeling medicinal chemistry and microbiology.

Faculty Supervisor:

Eric Marsault;François Malouin;François Malouin;Martin Audet;Pierre-Luc Boudreault

Student:

Partner:

Amorchem Therapeutics Inc;AmorChem Financial Inc

Discipline:

Life Sciences

Sector:

Finance and Insurance; Professional, scientific and technical services

University:

Université de Sherbrooke

Program:

Accelerate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe

Mitacs — Return on Innovation

Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.